Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 28, 2011 09:30 ET | Source: Repros Therapeutics Inc.

Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2010 Financial Results

THE WOODLANDS, Texas, March 28, 2011 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the year and fourth quarter ended December 31,...
March 16, 2011 09:30 ET | Source: Repros Therapeutics Inc.

Repros(R) Therapeutics Commences Dosing Third Cohort in Low Dose Proellex(R) Study

THE WOODLANDS, Texas, March 16, 2011 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX)today announced it has commenced dosing the 6 mg cohort in the Company's low dose study of...
March 15, 2011 10:05 ET | Source: Repros Therapeutics Inc.

Repros(R) Reports Results From Completed 1 mg Dose Cohort in Low Dose Proellex(R) Study

THE WOODLANDS, Texas, March 15, 2011 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (Nasdaq:RPRX) today announced it has completed its internal review of the results obtained for the 1 mg dose from...